A study of 328 endometrial cancer patients found that TFPI2 levels increased with disease stage and were linked to poorer five-year survival rates, although no direct correlation with immunohistochemical TFPI2 expression was found [15]. The gene discussed is TFPI2; the disease is endometrial cancer.